Feature | November 04, 2016| Dave Fornell

Most Popular DAIC Content in October 2016

One of the most popular articles on October was a post-procedure MRI study of transcatheter aortic valve replacement (TAVR) patients. It showed that showed 94 percent of patients have minor lesions in the brain due to procedural emboli. This has spurred additional interest in using embolic protection systems during TAVR procedures. 

November 4, 2016 — Here is the list of the top 20 most popular pieces of content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of October based on website analytics:  

1. 5 New Implantable Cardiovascular Technologies to Watch
 

2. Study Shows New Brain Lesions in 94 Percent of Patients Following TAVR
 

3. St. Jude Medical Recalls ICDs and CRT-D Due to Premature Battery Depletion
 

4. Improving Efficiencies With a Radial Access Sleeve Drape
 

5. St. Jude Medical, Abbott to Sell Portion of Vascular Closure, EP Businesses to Terumo
 

6. Study Shows Zip Skin Closure System Saves Time in the Cath Lab
 

7. Understanding the Design and Function of Guidewire Technology
 

8. Stents, Bypass Surgery Equally Safe and Effective for Many with Left Main Heart Disease
 

9. Updated ASE Guideline Simplifies Evaluation of Possible Heart Failure
 

10. Better Prognosis for Some PCI Patients When Operators Perform More Procedures
 

11. Requirements for Interventional Echocardiographers
 

12. First Bioresorbable Heart Valves Implanted to Enable Cardiovascular Restoration
 

13. What You Need to Know to Prepare for TCT 2016
 

14. FDA Changes Rules For Custom Medical Device Exemptions
 

15. Vascular Solutions Issues Recall of Twin-Pass Dual Access Catheters
 

16. 5 Technologies to Reduce Cath Lab Radiation Exposure
 

17. University Hospital Zurich Heart Team First to Perform Tricuspid Valve Repair with Cardioband
 

18. Late-Breaking Endovascular Clinical Trial Results Announced At VIVA 16
 

19. New Smartphone App Detects Heart Attacks
 

20. Robotics May Aid Implantation of Bioresorbable Stents
 

Related Content

Edwards Lifesciences Centera self expanding transcatheter (TAVR) valve has been approved with CE mark for use in Europe.
Feature | Heart Valve Technology | February 15, 2018
February 15, 2018 — Edwards Lifesciences Corp.
Boston Scientific Enters Investment and Acquisition Option Agreement With Millipede
News | Heart Valve Technology | January 24, 2018
Boston Scientific Corp. announced it has closed an investment and entered into an acquisition option agreement with...
Edwards LifeSciences Recalls Sapien 3 Certitude Delivery System
News | Heart Valve Technology | January 11, 2018
The U.S. Food and Drug Administration (FDA) announced that Edwards LifeSciences is recalling its Certitude Delivery...
Videos | Heart Valve Technology | January 04, 2018
Adam Greenbaum, M.D., co-director, Center for Structural Heart Disease, Henry Ford Hospital, Detroit, explains how hi
Edwards Acquires Harpoon Medical
News | Heart Valve Technology | December 07, 2017
December 7, 2017 — Edwards Lifesciences Corp.
Videos | Heart Valve Technology | November 15, 2017
Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, is the principal investigato
New Analyses Reinforce Hemodynamic Benefits of Evolut TAVR Platform in Intermediate-Risk Aortic Stenosis Patients
News | Heart Valve Technology | November 08, 2017
Medtronic plc recently presented new clinical research to support the positive clinical performance of the Evolut...
Videos | Heart Valve Technology | November 08, 2017
Stephen Worthley, MB, BS, Ph.D., director of cardiac catheterization, University of Adelaide, Australia, presents the
Videos | Heart Valve Technology | November 08, 2017
Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at Morris
Overlay Init